Allogeneic Transplantation for Chronic Lymphocytic Leukemia

Even if Chronic lymphocytic leukemia (CLL) often has an indolent behavior with good responsiveness to cytoreductive treatment, about 20% of the patients, so called “poor-risk” patients, show an aggressive course and die within a few years despite early intensive therapies. Criteria for poor-risk dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurenti, Luca, Tarnani, Michela, Chiusolo, Patrizia, Sorà, Federica, Sica, Simona
Formato: Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2010
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033136/
https://www.ncbi.nlm.nih.gov/pubmed/21415973
http://dx.doi.org/10.4084/MJHID.2010.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033136/
https://www.ncbi.nlm.nih.gov/pubmed/21415973
http://dx.doi.org/10.4084/MJHID.2010.026

Ejemplares similares